Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent, thanks for posting this. I was aware we were in the period for Tranche II but wasn't sure as to when we would have 30 days. Very important day for us.
HDVY Featured on a Scottrade Ad on Yahoo Finance!
Key Statistics
Forward P/E (1 yr): N/A
P/S (ttm): 731.04
Ex-Dividend Date: N/A
» More Key Statistics
Analysts
Annual EPS Est () : N/A
Quarterly EPS Est () : N/A
Mean Recommendation*: N/A
PEG Ratio (5 yr expected): N/A
* (Strong Buy) 1.0 - 5.0 (Sell)
Analyst Opinion | Estimates
Business Summary
Health Discovery Corporation operates as a pattern recognition company that uses mathematical techniques to analyze large amounts of data to uncover patterns in the United States. View More
Company Profile | Industry
Here is the link for Vermillion's update.
http://www.prnewswire.com/news-releases/vermillion-adds-peter-s-roddy-to-board-and-provides-corporate-update-84688827.html
Notice the conferences. Wonder if HDVY will be mentioned.
VERMILLION (VRML.PK) hitting its all time high today. Will be interesting to watch this: "Vermillion and Quest Diagnostics confirmed they are on track to launch OVA1™ in March 2010. The company plans to provide more detail at the time of commercialization".GLTA
Please Transfer my 401K from Fidelity to SVM Capital
"The composite of the four indices was up a total of 19% while our new SVM model was up over 20%, with lower risk. Again, the new SVM model outperformed the indices with lower risk."
GLTA
Excellent Response HDVY, I especially like this statement about the new, non-invasive, four-gene prostate cancer test:
"The Company stands by its public disclosures related to this test and is pleased with its continued progress".
HDVY Makes the "Best & Brightest" List
MDB Capital Group LLC announces its "Best and Brightest" list of 160 innovation leaders for the 1st Annual Bright Lights Conference to be held on May 10 - 12, 2010 at the Palace Hotel in San Francisco. Institutional investors from several countries, as well as IP
thought leaders, will be in attendance for the first public company conference to focus exclusively on companies with disruptive and market changing IP.
HDVY listed under "Life Science" section
http://www.itnewsonline.com/showprnstory.php?storyid=88804
Excellent Execution HDVY... Watch & Learn
Check this post from the Yahoo board...
"One of my buddies who works as a broker in NY just called and told me that the company is setting up a press conference to announce something. It looks like this thing has legs."
Maybe all of this activity will spur an update from the company.
GLTA.
Barnhill and Norris are speaking again at a conference February 22nd thru 24th. Hopfully we get the news we are all hoping for between now and then.
http://www.personalizedmedicinepartnerships.com/index.php?option=com_content&view=article&id=19&Itemid=18
Its Alive!!! Its Alive!!!
Financial News for HDVY
Hot Penny Stocks To Watch For 2/1/2010 - HDVY
StockExplode.com Penny Stock Watch List
USA 1/30/2010 11:00 AM GMT (TransWorldNews)
The StockExplode.com Hot Penny Stock Watch List For 2/1/2010 Includes:
Health Discovery Corporation (Public, OTC: HDVY)
Health Discovery Corporation (HDC) is a pattern recognition company that uses mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. The Company operates primarily in the emerging field of molecular diagnostics where such tools are critical to scientific discovery. The Company’s principal asset is its intellectual property, which includes mathematical algorithms called Support Vector Machines (SVM) and Fractal Genomic Modeling (FGM), as well as biomarkers that the Company discovered by applying its SVM and FGM techniques to complex genetic and proteomic data. HDC also endeavors to develop its own product line of newly discovered biomarkers and pathways that include human genes and genetic variations, as well as gene, and metabolite expression differences. The principal healthcare market for its pattern recognition technology and biomarker discoveries is medical diagnostics, particularly the field of molecular diagnostics.
For all other stocks on our watch list, our exclusive penny stock picks, plus breaking news alerts and analysis, please visit www.StockExplode.com
StockExplode.com jumping in on the action. Anyone else?
The StockExplode.com Hot Penny Stock Watch List For 2/1/2010 Includes HDVY....KABOOOM!!!!
Barnhill and Norris are speaking again at a conference February 22nd thru 24th. Hopfully we get the news we are all hoping for between now and then.
http://www.personalizedmedicinepartnerships.com/index.php?option=com_content&view=article&id=19&Itemid=18
Barnhill and Norris will speak at a conference on 1/26
http://www.worldcongress.com/agenda.cfm?level=inside&confCode=HL10001&agendaID=453&subAgendaID=1178
Interesting how this thing keeps getting whacked during the current news void. Would like to know who is scooping up all that paper.
Tic.. Tic.. Tic..
Yahooo!!! Tic.. Tic.. Tic.
Renmanaz, See posts 2757 and 2744 for T trades. Also, I posted about the posibility that Norris was not kept on due to the fact that we haven't seen an 8K which I think would be necessary if he was. Any thoughts?
What about Norris? Is he off the books or if he has stayed on, don't they have to file an 8K within a certain amount of time? Any thoughts?
From wisegeek.com: "Form T trading does present a few important advantages. If the investor happens to find out something that may have an effect on the price of a stock after hours, they have the convenience of acting on that information immediately. Otherwise, it would be necessary to wait until the markets open again, by which time the information will have reached many more investors, making it harder to profit from the situation. Form T trading also makes buying and selling U.S. stocks more convenient for foreign investors who operate outside the usual hours of trading in the U.S."
Renmanaz, Can you advise if you agree with the following: On 11/7/09, the company called 16,012,464 $0.17 Tranche 1 Warrants and as a result 6,241,928 shares of restricted common shares were purchased as of 11/13/09. In addition, the company received non binding commitments to purchase 1,697,142 shares which leaves a total of 8,073,394 shares that were called with a deadline for conversion on 11/19/09.
Some questions for the company (if you get through) might be:
(1) How many of the deadline called shares were purchased?
(2) How many of the deadline called shares were forfeited?
(3) Is the holding period for restricted paper still 2 years?
From the 10Q, f.y.i.:[url][/url][tag]insert-text-here[/tag]
"In addition, as previously reported on our Annual Report on Form 10-K for the fiscal year ended December 31, 2008, in connection with our 2007 private placement, we issued warrants to purchase 51,538,822 shares of restricted common stock at an exercise price of $0.14 (the “Tranche 1 Warrants”). Pursuant to the terms of the Tranche 1 Warrants, the holders must exercise fifty percent of the Tranche 1 Warrants if the market price for the Company’s common stock is $0.17 for a period of thirty consecutive calendar days, which occurred on November 6, 2009, or forfeit the right to acquire those shares. On November 7, 2009, we exercised our call rights under certain of the Tranche 1 Warrants. As a result, the holders of the Tranche 1 Warrants who received the Company’s call notice must purchase 16,012,464 shares of restricted common stock or forfeit an equal number of Tranche 1 Warrants. As of November 13, 2009, 6,241,928 shares of our common stock have been purchased in connection with the Company’s call of the Tranche 1 Warrants, and we have received $873,869.92 in gross proceeds from the purchase of the common stock. We have also received non-binding commitments to purchase 1,697,142 shares for gross proceeds of $237,599.88. By November 19, 2009, all holders of the remaining Tranche 1 Warrants who received the Company’s call notice will have had to elect whether to exercise the portion of the Tranche 1 Warrants called by the Company.
insert-text-here
I agree that there continues to be concern as to amount of warrants and the resulting dilution from exercise. The positive is the cash that the company can raise with the negative result of dilution to existing shareholders. It is important that the money is used to increase shareholder value and not used to line the pockets of officers with bonuses. I think it would be great if they could use some of the money to increase our stake in Smart Personalized Medicine (the breast cancer venture)since the pattern recognition technology has been validated recently as evidenced by what has happend to Vermillion and the agreements with Quest and Abbott. Please advise if you have been able to get through to Scott. Would be interested as to an updated about the warrants. Many thanks.
Teaks: Congratulations on the print and .05 close!
Hi Big K. Can you post a link for that. I think a change of name is in the cards but not sure when it might happen.
Thanks. Good to be here. http://www.snl.com/irweblinkx/corporateprofile.aspx?iid=4112593